Discriminatory value of plasma NfL, total tau, Aβ42, Aβ40, Aβ42/40 and α-syn as a single biomarker and as part of plasma biomarker panel in differentiating MSA from PSP. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.